This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Martin James Ford: Innovator in Vaccine Technology
Introduction
Martin James Ford is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of vaccine technology, particularly through his innovative work on liposomes. His research focuses on creating effective vaccine delivery systems that can enhance immune responses.
Latest Patents
Ford holds a patent for "Fusogenic liposomes that are free of active neuraminidase." This invention involves liposomes that possess a polypeptide on their surface, which is capable of binding to mucosal cell surfaces in humans or animals. These liposomes are designed to be substantially free of active neuraminidase, making them useful as vaccines. This patent highlights his commitment to advancing medical technology and improving vaccine efficacy.
Career Highlights
Throughout his career, Martin James Ford has been associated with Burroughs Wellcome Co., where he has contributed to various research initiatives. His work has focused on developing innovative solutions in the pharmaceutical industry, particularly in vaccine development. His expertise in liposome technology has positioned him as a key figure in this area of research.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Martin James Ford's contributions to vaccine technology through his innovative patent on fusogenic liposomes demonstrate his dedication to improving public health. His work continues to influence the field and pave the way for future advancements in vaccine delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile